Titre : | Dual diagnosis and successful participation of adolescents in substance abuse treatment |
Titre traduit : | (Double diagnostic et suivi du traitement chez des 'adolescents usagers de drogues) |
Auteurs : | WISE B. K. ; CUFFE S. P. ; T. FISCHER |
Type de document : | Périodique |
Année de publication : | 2001 |
Format : | 161-165 / tabl. |
Note générale : |
Journal of Substance Abuse Treatment, 2001, 21, (3), 161-165 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés COMORBIDITE ; ADOLESCENT ; DEPENDANCE ; PREVALENCE ; TRAITEMENT RESIDENTIEL ; OBSERVANCE DU TRAITEMENTThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : A retrospective record review of one year of admissions to a residential adolescent substance abuse treatment program (N=91) examined the prevalence of comorbid psychiatric disorders and factors associated with successful treatment participation. Psychiatric and substance use disorders (SUD) were diagnosed by DSM-IV criteria. Successful participation was based on multiple factors assessed by the treatment team. Consistent with prior studies, there was considerable comorbidity (63.7%) with both disruptive (Attention Deficit Hyperactivity Disorder [ADHD], 11%; Conduct Disorder [CD], 24%) and other disorders (depression, 24%; adjustment disorder, 7.7%; bipolar disorder, 3.3%). Male gender was negatively associated (OR=0.23, P=0.019) with successful participation in univariate analyses, as was ADHD (OR=0.18, P=0.007). CD (OR=0.37, P=0.053) approached significance. Multivariate analysis reveals ADHD was significant while having CD and being mate approached significance. Psychotropic medication use and other diagnoses were not associated with successful participation. It is concluded that further research on the relationship between ADHD, CD, and substance abuse treatment is needed. (Editor's abstract.) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 28 |
Affiliation : |
Dept. Psychiat. Univ. Colorado, Denver, CO. E-mail : spc45@wshpi.dmh.state.sc.us Etats-Unis. United States. |
Numéro Toxibase : | 403756 |
Centre Emetteur : | 04 CIRDD-51 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil